Cargando…

Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity

Mucosal-associated invariant T (MAIT) cells belong to a family of innate-like T cells that bridge innate and adaptive immunities. Although MAIT cells have been implicated in tumor immunity, it currently remains unclear whether they function as tumor-promoting or inhibitory cells. Therefore, we herei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugimoto, Chie, Murakami, Yukie, Ishii, Eisuke, Fujita, Hiroyoshi, Wakao, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983048/ https://www.ncbi.nlm.nih.gov/pubmed/35379387 http://dx.doi.org/10.7554/eLife.70848

Ejemplares similares

Harnessing the Power of Mucosal-Associated Invariant T (MAIT) Cells in Cancer Cell Therapy
por: Sugimoto, Chie, et al.
Publicado: (2022)

Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis
por: Sugimoto, Chie, et al.
Publicado: (2015)

Mucosal-Associated Invariant T Cells in Regenerative Medicine
por: Wakao, Hiroshi, et al.
Publicado: (2017)

The dynamics of mucosal-associated invariant T cells in multiple sclerosis
por: Sugimoto, Chie, et al.
Publicado: (2016)

Mucosal-associated invariant T cells repress group 2 innate lymphoid cells in Alternaria alternata-induced model of allergic airway inflammation
por: Shimizu, Yasuo, et al.
Publicado: (2022)

A flow-cytometry-based assay to assess the cytolytic activity against tumor cells by combination of mouse MAIT cells and natural killer cells
por: Sugimoto, Chie, et al.
Publicado: (2023)

Epigenetic silencing of V(D)J recombination is a major determinant for selective differentiation of mucosal-associated invariant t cells from induced pluripotent stem cells
por: Saito, Yutaka, et al.
Publicado: (2017)

Fibroblast rejuvenation by mechanical reprogramming and redifferentiation
por: Roy, Bibhas, et al.
Publicado: (2020)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

MITF reprograms the extracellular matrix and focal adhesion in melanoma
por: Dilshat, Ramile, et al.
Publicado: (2021)

Toward the realization of cell therapy: The advent of MAIT cells from iPSCs
por: Wakao, Hiroshi, et al.
Publicado: (2013)

Strategies to Modulate the Redifferentiation of Chondrocytes
por: Hu, Xiaoshen, et al.
Publicado: (2021)

Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the inhibitory immunoreceptor CD300a
por: Nakazawa, Yuta, et al.
Publicado: (2021)

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
por: Bhagat, Tushar D, et al.
Publicado: (2019)

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies
por: Hwang, Justin H, et al.
Publicado: (2022)

Characteristics of cultured desmoid cells with different CTNNB1 mutation status
por: Hamada, Shunsuke, et al.
Publicado: (2015)

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
por: Urabe, Masayuki, et al.
Publicado: (2018)

Redifferentiated Chondrocytes for the Repair of Articular Cartilage Lesions
por: Bianchi, Vanessa Juliana, et al.
Publicado: (2017)

Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo
por: Nishioka, Chie, et al.
Publicado: (2015)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Charactering tumor microenvironment reveals stromal‐related transcription factors promote tumor carcinogenesis in gastric cancer
por: Liu, Haining, et al.
Publicado: (2020)

Open pipelines for integrated tumor genome profiles reveal differences between pancreatic cancer tumors and cell lines
por: Goecks, Jeremy, et al.
Publicado: (2015)

Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment
por: Miyata, Kenichi, et al.
Publicado: (2014)

Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma
por: Dai, Wei, et al.
Publicado: (2015)

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
por: Gou, Xuxu, et al.
Publicado: (2023)

Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63
por: Tanaka, Nobuyuki, et al.
Publicado: (2018)

EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
por: Lin, Zong-Shin, et al.
Publicado: (2023)

Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2
por: Liu, You Dong, et al.
Publicado: (2019)

Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN
por: Kaneko, Mika K., et al.
Publicado: (2017)

Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma
por: Kawano, Kumi, et al.
Publicado: (2013)

In vivo imaging xenograft models for the evaluation of anti‐brain tumor efficacy of targeted drugs
por: Kita, Kenji, et al.
Publicado: (2017)

Antiproliferation and Redifferentiation in Thyroid Cancer Cell Lines by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

The Interplay between Chondrocyte Redifferentiation Pellet Size and Oxygen Concentration
por: Babur, Betul Kul, et al.
Publicado: (2013)

Redifferentiation of expanded human islet β cells by inhibition of ARX
por: Friedman-Mazursky, Orr, et al.
Publicado: (2016)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells
por: Fukagawa, Akihiko, et al.
Publicado: (2015)

Development of mucosal‐associated invariant T cells
por: Koay, Hui‐Fern, et al.
Publicado: (2018)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

High-content microscopy reveals a morphological signature of bortezomib resistance
por: Kelley, Megan E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fdpuiid3edt4gaakllo12q7ngr